| Literature DB >> 32041190 |
Nadia Minian1,2,3, Anna Ivanova1, Sabrina Voci1, Scott Veldhuizen1, Laurie Zawertailo1,4, Dolly Baliunas1,5, Aliya Noormohamed1, Norman Giesbrecht5,6, Peter Selby1,2,3,5,7.
Abstract
Although brief alcohol intervention can reduce alcohol use for both men and women, health care providers (HCPs) are less likely to discuss alcohol use or deliver brief intervention to women compared to men. This secondary analysis examined whether previously reported outcomes from a cluster randomized trial of a clinical decision support system (CDSS)-prompting delivery of a brief alcohol intervention (an educational alcohol resource) for patients drinking above cancer guidelines-were moderated by patients' sex. Patients (n = 5702) enrolled in a smoking cessation program at primary care sites across Ontario, Canada, were randomized to either the intervention (CDSS) or control arm (no CDSS). Logistic generalized estimating equations models were fit for the primary and secondary outcome (HCP offer of resource and patient acceptance of resource, respectively). Previously reported results showed no difference between treatment arms in HCP offers of an educational alcohol resource to eligible patients, but there was increased acceptance of the alcohol resource among patients in the intervention arm. The results of this study showed that these CDSS intervention effects were not moderated by sex, and this can help inform the development of a scalable strategy to overcome gender disparities in alcohol intervention seen in other studies.Entities:
Keywords: alcohol; brief intervention; clinical decision support systems; sex differences; smoking cessation; tobacco
Year: 2020 PMID: 32041190 PMCID: PMC7037372 DOI: 10.3390/ijerph17031024
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Baseline patient characteristics for the main analytic sample (n = 5702).
| Variables | Control | Intervention | ||
|---|---|---|---|---|
| Male | Female | Male | Female | |
| ( | ( | ( | ( | |
| Age in years (mean, SD) | 49.1 (13.5) | 46.9 (13.8) | 48.5 (13.6) | 46.8 (13.4) |
| Graduated high school | 1033 (67) | 977 (78) | 1071 (68) | 997 (76) |
| Household income above $40,000 | 532 (34) | 373 (30) | 495 (31) | 372 (28) |
| Currently employed | 827 (53) | 660 (53) | 829 (52) | 693 (53) |
| Daily smoking status | 1430 (92) | 1177 (94) | 1506 (94) | 1238 (94) |
| Heaviness of smoking index > 3 | 417 (29) | 229 (19) | 441 (29) | 273 (22) |
| Number of alcoholic drinks in past week (mean, SD) | 12.9 (14.3) | 7.6 (9.4) | 12.5 (14.7) | 8.2 (10.6) |
| Above AUDIT-C cut off | 1270 (82) | 1018 (82) | 1290 (81) | 1080 (82) |
| Above AUDIT-10 cut off | 67 (4) | 33 (3) | 97 (6) | 43 (3) |
| Past year attempts to quit smoking | 797 (52) | 631 (51) | 808 (51) | 685 (52) |
| Lifetime attempts to quit smoking ≥ 11 | 261 (17) | 180 (14) | 293 (18) | 185 (14) |
| Marijuana use in past 30 days | 546 (35) | 303 (24) | 599 (38) | 367 (28) |
| Opioid use in past 30 days | 244 (16) | 175 (14) | 244 (15) | 189 (14) |
| Number of comorbid conditions endorsed 1 (mean, SD) | 2.3 (2.0) | 2.4 (2.0) | 2.5 (2.1) | 2.4 (2.0) |
Note: Values are numbers (percentages) unless stated otherwise. SD = standard deviation. 1 Possible comorbid conditions (lifetime history of diagnosis) included: high blood pressure, high cholesterol, heart disease, stroke, diabetes, chronic bronchitis/emphysema/chronic obstructive pulmonary disease, rheumatoid arthritis, chronic pain, cancer, depression, anxiety, schizophrenia, bipolar disorder, substance use disorder, alcohol use disorder, or problem gambling.
Figure 1Proportion of men and women exceeding safe drinking guidelines (a) that were offered an appropriate educational alcohol resource by their health care provider in each treatment arm; (b) that accepted the offer of an educational alcohol resource by their health care provider in each treatment arm. CDSS = clinical decision support system.
Adjusted odds ratios and 95% confidence intervals for offer and acceptance of an educational alcohol resource.
|
| ||||||
|
|
|
| ||||
|
|
|
|
|
|
| |
| CDSS | 1.20 (0.88–1.64) | 0.25 | 1.20 (0.88–1.64) | 0.25 | 1.24 (0.90–1.72) | 0.19 |
| Female patient | - | - | 0.92 (0.82–1.03) | 0.13 | 0.95 (0.82–1.11) | 0.51 |
| CDSS × Sex interaction term | - | - | - | - | 0.93 (0.74–1.16) | 0.53 |
|
| ||||||
|
|
|
| ||||
|
|
|
|
|
|
| |
| CDSS | 1.49 (1.01–2.18) | 0.04 | 1.48 (1.01–2.16) | 0.046 | 1.70 (1.12–2.57) | 0.01 |
| Female patient | - | - | 1.12 (0.93–1.37) | 0.24 | 1.33 (0.96–1.86) | 0.09 |
| CDSS × Sex interaction term | - | - | - | - | 0.74 (0.50–1.09) | 0.13 |
Note: Site stratification variables (i.e., clinic size and clinic type) were included as covariates.